Società Finanziaria Regione Sardegna, SpA

(SFIRS) is dedicated to the economic and social development of companies based in Sardinia, such as ViroStatics. In 2007, ViroStatics raised approximately €10 million euro through a Series A financing with SFIRS.

The Research Institute for Genetic and Human Therapy

(RIGHT) is a not-for-profit 501(c)(3) organization based in USA and Italy. The parent company of ViroStatics, RIGHT is an international institute pursuing innovative therapies and vaccine research in the area of HIV/AIDS and other chronic, life-threatening diseases.

CMC & Quality System

(CMC&QS) is a consulting Company offering a wide range of services to support Chemistry, Manufacturing & Controls (CMC) activities and Quality Systems at any stage in the pharmaceutical development process from research to commercialization.

Genetic Immunity

Is a privately held US / Hungarian clinical-stage biotechnology company focusing on the discovery, development and commercialization of personalized Immune Therapies (Therapeutic Vaccines). Genetic Immunity’s products are designed to boost specific immune responses to modify or control these presently incurable diseases.

The University of Siena

Has licensed a library of over 300 compounds to ViroStatics and the Company has established an ongoing chemical synthesis collaboration with the University to further enhance our AV-HALT discovery program.

Vichem Chemie

Provides ViroStatics with advanced medicinal chemistry services based on their Nested Chemical Library™ (NCL).  NCL is organized around 108 core structures and more than 300 scaffolds, and contains inhibitors against 124 kinases, providing the most diverse kinase inhibitory library available for drug research.